Search:
 
This image is of a spacer graphic
NHF Face Book NHF Twitter
+ Login to my NHF
+ NHF Membership
+ Donate to NHF
+ Chapter Center
+ Hechos y Respuestas Rápidas
+ Ethics Advisory Committee
This image is of a spacer graphic
-News
 NHF In The News
 NHF eNotes
 Medical Advisories
 Advocacy and Legislative Updates
 Medical News
 Blood Safety News
-NHF and Community News
 Industry News
 Travel Advisory

 

 

 
Campaign Update
 

With more than 90% of the goal reached for Campaign for Our Future, NHF recently launched the second phase of the fundraising campaign. Phase II--Campaign for Our Future, Research is Our Future--has a specific focus on research, because research is our future.

For more than 60 years, NHF has been a leader in the field of scientific research for bleeding disorders and remains the largest nongovernmental organization committed to this type of science. Currently, there is no dedicated source of funding for the critical research that must be done to continue improving treatments and one day find a cure.

That is why we count on individuals like you. In fact, most every major medical advancement in the treatment and care of people with bleeding disorders has been made possible through funding from individuals.

Go to Campaign for Our Future to learn more or to make a contribution.

The Visionary Corporate Partner and Lead Benefactor for Campaign for Our Future is Novo Nordisk. Other major sponsors include: Baxter, Principal Corporate Partner; Bayer, CSL Behring and Pfizer, Major Corporate Partners; and Grifols, Corporate Partner.

 

This section of our Web site is sponsored by: